Skip to main navigation Skip to search Skip to main content

Engineered adipokine receptor inhibitor for the treatment of triple negative breast cancer in obese patients

Project Details

StatusFinished
Effective start/end date1/09/21 → 28/02/23

Funding

  • Tulane University: $9,071.00

Keywords

  • Biotechnology & Drug Development, Cancer Research, Translational